0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rubella Virus Antigen Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-3F19232
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Rubella Virus Antigen Market Research Report 2025
BUY CHAPTERS

Global Rubella Virus Antigen Market Research Report 2025

Code: QYRE-Auto-3F19232
Report
March 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rubella Virus Antigen Market Size

The global market for Rubella Virus Antigen was valued at US$ 109 million in the year 2024 and is projected to reach a revised size of US$ 136 million by 2031, growing at a CAGR of 2.7% during the forecast period.

Rubella Virus Antigen Market

Rubella Virus Antigen Market

Rubella Virus Antigen refers to specific proteins or components of the rubella virus that are used in diagnostic tests to detect the presence of rubella virus infection in a patient. Rubella is a contagious viral infection that typically causes a mild rash and fever, but can have serious consequences when contracted by pregnant women, particularly during the first trimester, leading to birth defects or miscarriage.The Rubella Virus Antigen is often detected in laboratory tests such as enzyme-linked immunosorbent assays (ELISA) or polymerase chain reaction (PCR) methods. These antigens are primarily derived from the rubella virus’ coat proteins, which trigger an immune response in the body. During an infection, the immune system recognizes these antigens as foreign and produces antibodies against them.
North American market for Rubella Virus Antigen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rubella Virus Antigen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Rubella Virus Antigen in In Vitro Diagnostics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Rubella Virus Antigen include Creative Biomart, RayBiotech, ProSpec, Abcam, Bio-Rad Laboratories, Fapon Biotech, QED Bioscience, Cusabio, Meridian Bioscience, Native Antigen Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rubella Virus Antigen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rubella Virus Antigen.
The Rubella Virus Antigen market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rubella Virus Antigen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rubella Virus Antigen companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rubella Virus Antigen Market Report

Report Metric Details
Report Name Rubella Virus Antigen Market
Accounted market size in year US$ 109 million
Forecasted market size in 2031 US$ 136 million
CAGR 2.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • In Vitro Diagnostics
  • Vaccine Development
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Creative Biomart, RayBiotech, ProSpec, Abcam, Bio-Rad Laboratories, Fapon Biotech, QED Bioscience, Cusabio, Meridian Bioscience, Native Antigen Company, SERION Immunologics, ViroGen Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Rubella Virus Antigen company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Rubella Virus Antigen Market growing?

Ans: The Rubella Virus Antigen Market witnessing a CAGR of 2.7% during the forecast period 2025-2031.

What is the Rubella Virus Antigen Market size in 2031?

Ans: The Rubella Virus Antigen Market size in 2031 will be US$ 136 million.

Who are the main players in the Rubella Virus Antigen Market report?

Ans: The main players in the Rubella Virus Antigen Market are Creative Biomart, RayBiotech, ProSpec, Abcam, Bio-Rad Laboratories, Fapon Biotech, QED Bioscience, Cusabio, Meridian Bioscience, Native Antigen Company, SERION Immunologics, ViroGen Corporation

What are the Application segmentation covered in the Rubella Virus Antigen Market report?

Ans: The Applications covered in the Rubella Virus Antigen Market report are In Vitro Diagnostics, Vaccine Development, Others

What are the Type segmentation covered in the Rubella Virus Antigen Market report?

Ans: The Types covered in the Rubella Virus Antigen Market report are Rubella Protein Purity >90%, Rubella Protein Purity >95%, Rubella Protein Purity >98%, Others

Recommended Reports

Antigen and Diagnostics

Viral Vaccines Market

Innovative Vaccine Technologies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rubella Virus Antigen Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Rubella Protein Purity >90%
1.2.3 Rubella Protein Purity >95%
1.2.4 Rubella Protein Purity >98%
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rubella Virus Antigen Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 In Vitro Diagnostics
1.3.3 Vaccine Development
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rubella Virus Antigen Market Perspective (2020-2031)
2.2 Global Rubella Virus Antigen Growth Trends by Region
2.2.1 Global Rubella Virus Antigen Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Rubella Virus Antigen Historic Market Size by Region (2020-2025)
2.2.3 Rubella Virus Antigen Forecasted Market Size by Region (2026-2031)
2.3 Rubella Virus Antigen Market Dynamics
2.3.1 Rubella Virus Antigen Industry Trends
2.3.2 Rubella Virus Antigen Market Drivers
2.3.3 Rubella Virus Antigen Market Challenges
2.3.4 Rubella Virus Antigen Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rubella Virus Antigen Players by Revenue
3.1.1 Global Top Rubella Virus Antigen Players by Revenue (2020-2025)
3.1.2 Global Rubella Virus Antigen Revenue Market Share by Players (2020-2025)
3.2 Global Top Rubella Virus Antigen Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rubella Virus Antigen Revenue
3.4 Global Rubella Virus Antigen Market Concentration Ratio
3.4.1 Global Rubella Virus Antigen Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rubella Virus Antigen Revenue in 2024
3.5 Global Key Players of Rubella Virus Antigen Head office and Area Served
3.6 Global Key Players of Rubella Virus Antigen, Product and Application
3.7 Global Key Players of Rubella Virus Antigen, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rubella Virus Antigen Breakdown Data by Type
4.1 Global Rubella Virus Antigen Historic Market Size by Type (2020-2025)
4.2 Global Rubella Virus Antigen Forecasted Market Size by Type (2026-2031)
5 Rubella Virus Antigen Breakdown Data by Application
5.1 Global Rubella Virus Antigen Historic Market Size by Application (2020-2025)
5.2 Global Rubella Virus Antigen Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Rubella Virus Antigen Market Size (2020-2031)
6.2 North America Rubella Virus Antigen Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Rubella Virus Antigen Market Size by Country (2020-2025)
6.4 North America Rubella Virus Antigen Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rubella Virus Antigen Market Size (2020-2031)
7.2 Europe Rubella Virus Antigen Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Rubella Virus Antigen Market Size by Country (2020-2025)
7.4 Europe Rubella Virus Antigen Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rubella Virus Antigen Market Size (2020-2031)
8.2 Asia-Pacific Rubella Virus Antigen Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Rubella Virus Antigen Market Size by Region (2020-2025)
8.4 Asia-Pacific Rubella Virus Antigen Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rubella Virus Antigen Market Size (2020-2031)
9.2 Latin America Rubella Virus Antigen Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Rubella Virus Antigen Market Size by Country (2020-2025)
9.4 Latin America Rubella Virus Antigen Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rubella Virus Antigen Market Size (2020-2031)
10.2 Middle East & Africa Rubella Virus Antigen Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Rubella Virus Antigen Market Size by Country (2020-2025)
10.4 Middle East & Africa Rubella Virus Antigen Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biomart
11.1.1 Creative Biomart Company Details
11.1.2 Creative Biomart Business Overview
11.1.3 Creative Biomart Rubella Virus Antigen Introduction
11.1.4 Creative Biomart Revenue in Rubella Virus Antigen Business (2020-2025)
11.1.5 Creative Biomart Recent Development
11.2 RayBiotech
11.2.1 RayBiotech Company Details
11.2.2 RayBiotech Business Overview
11.2.3 RayBiotech Rubella Virus Antigen Introduction
11.2.4 RayBiotech Revenue in Rubella Virus Antigen Business (2020-2025)
11.2.5 RayBiotech Recent Development
11.3 ProSpec
11.3.1 ProSpec Company Details
11.3.2 ProSpec Business Overview
11.3.3 ProSpec Rubella Virus Antigen Introduction
11.3.4 ProSpec Revenue in Rubella Virus Antigen Business (2020-2025)
11.3.5 ProSpec Recent Development
11.4 Abcam
11.4.1 Abcam Company Details
11.4.2 Abcam Business Overview
11.4.3 Abcam Rubella Virus Antigen Introduction
11.4.4 Abcam Revenue in Rubella Virus Antigen Business (2020-2025)
11.4.5 Abcam Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Rubella Virus Antigen Introduction
11.5.4 Bio-Rad Laboratories Revenue in Rubella Virus Antigen Business (2020-2025)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Fapon Biotech
11.6.1 Fapon Biotech Company Details
11.6.2 Fapon Biotech Business Overview
11.6.3 Fapon Biotech Rubella Virus Antigen Introduction
11.6.4 Fapon Biotech Revenue in Rubella Virus Antigen Business (2020-2025)
11.6.5 Fapon Biotech Recent Development
11.7 QED Bioscience
11.7.1 QED Bioscience Company Details
11.7.2 QED Bioscience Business Overview
11.7.3 QED Bioscience Rubella Virus Antigen Introduction
11.7.4 QED Bioscience Revenue in Rubella Virus Antigen Business (2020-2025)
11.7.5 QED Bioscience Recent Development
11.8 Cusabio
11.8.1 Cusabio Company Details
11.8.2 Cusabio Business Overview
11.8.3 Cusabio Rubella Virus Antigen Introduction
11.8.4 Cusabio Revenue in Rubella Virus Antigen Business (2020-2025)
11.8.5 Cusabio Recent Development
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Details
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Rubella Virus Antigen Introduction
11.9.4 Meridian Bioscience Revenue in Rubella Virus Antigen Business (2020-2025)
11.9.5 Meridian Bioscience Recent Development
11.10 Native Antigen Company
11.10.1 Native Antigen Company Company Details
11.10.2 Native Antigen Company Business Overview
11.10.3 Native Antigen Company Rubella Virus Antigen Introduction
11.10.4 Native Antigen Company Revenue in Rubella Virus Antigen Business (2020-2025)
11.10.5 Native Antigen Company Recent Development
11.11 SERION Immunologics
11.11.1 SERION Immunologics Company Details
11.11.2 SERION Immunologics Business Overview
11.11.3 SERION Immunologics Rubella Virus Antigen Introduction
11.11.4 SERION Immunologics Revenue in Rubella Virus Antigen Business (2020-2025)
11.11.5 SERION Immunologics Recent Development
11.12 ViroGen Corporation
11.12.1 ViroGen Corporation Company Details
11.12.2 ViroGen Corporation Business Overview
11.12.3 ViroGen Corporation Rubella Virus Antigen Introduction
11.12.4 ViroGen Corporation Revenue in Rubella Virus Antigen Business (2020-2025)
11.12.5 ViroGen Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Rubella Virus Antigen Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Rubella Protein Purity >90%
 Table 3. Key Players of Rubella Protein Purity >95%
 Table 4. Key Players of Rubella Protein Purity >98%
 Table 5. Key Players of Others
 Table 6. Global Rubella Virus Antigen Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Rubella Virus Antigen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Rubella Virus Antigen Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Rubella Virus Antigen Market Share by Region (2020-2025)
 Table 10. Global Rubella Virus Antigen Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Rubella Virus Antigen Market Share by Region (2026-2031)
 Table 12. Rubella Virus Antigen Market Trends
 Table 13. Rubella Virus Antigen Market Drivers
 Table 14. Rubella Virus Antigen Market Challenges
 Table 15. Rubella Virus Antigen Market Restraints
 Table 16. Global Rubella Virus Antigen Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Rubella Virus Antigen Market Share by Players (2020-2025)
 Table 18. Global Top Rubella Virus Antigen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Virus Antigen as of 2024)
 Table 19. Ranking of Global Top Rubella Virus Antigen Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Rubella Virus Antigen Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Rubella Virus Antigen, Headquarters and Area Served
 Table 22. Global Key Players of Rubella Virus Antigen, Product and Application
 Table 23. Global Key Players of Rubella Virus Antigen, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Rubella Virus Antigen Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Rubella Virus Antigen Revenue Market Share by Type (2020-2025)
 Table 27. Global Rubella Virus Antigen Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Rubella Virus Antigen Revenue Market Share by Type (2026-2031)
 Table 29. Global Rubella Virus Antigen Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Rubella Virus Antigen Revenue Market Share by Application (2020-2025)
 Table 31. Global Rubella Virus Antigen Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Rubella Virus Antigen Revenue Market Share by Application (2026-2031)
 Table 33. North America Rubella Virus Antigen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Rubella Virus Antigen Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Rubella Virus Antigen Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Rubella Virus Antigen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Rubella Virus Antigen Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Rubella Virus Antigen Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Rubella Virus Antigen Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Rubella Virus Antigen Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Rubella Virus Antigen Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Rubella Virus Antigen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Rubella Virus Antigen Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rubella Virus Antigen Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Rubella Virus Antigen Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Rubella Virus Antigen Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Rubella Virus Antigen Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Creative Biomart Company Details
 Table 49. Creative Biomart Business Overview
 Table 50. Creative Biomart Rubella Virus Antigen Product
 Table 51. Creative Biomart Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 52. Creative Biomart Recent Development
 Table 53. RayBiotech Company Details
 Table 54. RayBiotech Business Overview
 Table 55. RayBiotech Rubella Virus Antigen Product
 Table 56. RayBiotech Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 57. RayBiotech Recent Development
 Table 58. ProSpec Company Details
 Table 59. ProSpec Business Overview
 Table 60. ProSpec Rubella Virus Antigen Product
 Table 61. ProSpec Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 62. ProSpec Recent Development
 Table 63. Abcam Company Details
 Table 64. Abcam Business Overview
 Table 65. Abcam Rubella Virus Antigen Product
 Table 66. Abcam Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 67. Abcam Recent Development
 Table 68. Bio-Rad Laboratories Company Details
 Table 69. Bio-Rad Laboratories Business Overview
 Table 70. Bio-Rad Laboratories Rubella Virus Antigen Product
 Table 71. Bio-Rad Laboratories Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 72. Bio-Rad Laboratories Recent Development
 Table 73. Fapon Biotech Company Details
 Table 74. Fapon Biotech Business Overview
 Table 75. Fapon Biotech Rubella Virus Antigen Product
 Table 76. Fapon Biotech Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 77. Fapon Biotech Recent Development
 Table 78. QED Bioscience Company Details
 Table 79. QED Bioscience Business Overview
 Table 80. QED Bioscience Rubella Virus Antigen Product
 Table 81. QED Bioscience Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 82. QED Bioscience Recent Development
 Table 83. Cusabio Company Details
 Table 84. Cusabio Business Overview
 Table 85. Cusabio Rubella Virus Antigen Product
 Table 86. Cusabio Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 87. Cusabio Recent Development
 Table 88. Meridian Bioscience Company Details
 Table 89. Meridian Bioscience Business Overview
 Table 90. Meridian Bioscience Rubella Virus Antigen Product
 Table 91. Meridian Bioscience Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 92. Meridian Bioscience Recent Development
 Table 93. Native Antigen Company Company Details
 Table 94. Native Antigen Company Business Overview
 Table 95. Native Antigen Company Rubella Virus Antigen Product
 Table 96. Native Antigen Company Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 97. Native Antigen Company Recent Development
 Table 98. SERION Immunologics Company Details
 Table 99. SERION Immunologics Business Overview
 Table 100. SERION Immunologics Rubella Virus Antigen Product
 Table 101. SERION Immunologics Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 102. SERION Immunologics Recent Development
 Table 103. ViroGen Corporation Company Details
 Table 104. ViroGen Corporation Business Overview
 Table 105. ViroGen Corporation Rubella Virus Antigen Product
 Table 106. ViroGen Corporation Revenue in Rubella Virus Antigen Business (2020-2025) & (US$ Million)
 Table 107. ViroGen Corporation Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Rubella Virus Antigen Picture
 Figure 2. Global Rubella Virus Antigen Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rubella Virus Antigen Market Share by Type: 2024 VS 2031
 Figure 4. Rubella Protein Purity >90% Features
 Figure 5. Rubella Protein Purity >95% Features
 Figure 6. Rubella Protein Purity >98% Features
 Figure 7. Others Features
 Figure 8. Global Rubella Virus Antigen Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Rubella Virus Antigen Market Share by Application: 2024 VS 2031
 Figure 10. In Vitro Diagnostics Case Studies
 Figure 11. Vaccine Development Case Studies
 Figure 12. Others Case Studies
 Figure 13. Rubella Virus Antigen Report Years Considered
 Figure 14. Global Rubella Virus Antigen Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Rubella Virus Antigen Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Rubella Virus Antigen Market Share by Region: 2024 VS 2031
 Figure 17. Global Rubella Virus Antigen Market Share by Players in 2024
 Figure 18. Global Rubella Virus Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Rubella Virus Antigen Revenue in 2024
 Figure 20. North America Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Rubella Virus Antigen Market Share by Country (2020-2031)
 Figure 22. United States Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Rubella Virus Antigen Market Share by Country (2020-2031)
 Figure 26. Germany Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Rubella Virus Antigen Market Share by Region (2020-2031)
 Figure 34. China Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Rubella Virus Antigen Market Share by Country (2020-2031)
 Figure 42. Mexico Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Rubella Virus Antigen Market Share by Country (2020-2031)
 Figure 46. Turkey Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Rubella Virus Antigen Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Creative Biomart Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 50. RayBiotech Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 51. ProSpec Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 52. Abcam Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 54. Fapon Biotech Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 55. QED Bioscience Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 56. Cusabio Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 57. Meridian Bioscience Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 58. Native Antigen Company Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 59. SERION Immunologics Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 60. ViroGen Corporation Revenue Growth Rate in Rubella Virus Antigen Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart